We studied the effects of spinal intrathecal fentanyl on oxytocin secretion in 20 healthy women prior to an elective caesarean delivery at term under spinal anaesthesia. The women were randomly allocated into two groups with respect to spinal anaesthesia. Group I (n l 10) received intrathecal bupivacaine (15 mg) plus fentanyl (25 µg), and Group II (n l 10) received intrathecal bupivacaine (15 mg) alone, prior to caesarean section. The two groups were comparable demographically. Altogether, ten samples of 4.5 ml of blood (taken every 60 s) were obtained before and ten samples were obtained after the intrathecal administration of the drug and establishment of the T6 block, and plasma oxytocin concentrations were assayed for each subject. Oxytocin was measured by RIA. We found no significant differences in plasma oxytocin concentrations of individual subjects before and after intrathecal injection. In addition, there were no significant differences in plasma oxytocin concentrations between the two groups when pooled samples from the subjects were compared for the pre-and post-intrathecal injection phases. We conclude that the spinal intrathecal administration of fentanyl does not suppress oxytocin secretion in pregnant women who are not in labour at term.
INTRODUCTION
The control mechanisms that regulate oxytocin secretion in the human have not been fully elucidated to date. Previous research has suggested that the predominant mechanism of control is the inhibition of oxytocin secretion by endogenous opioids [1, 2] . Lindow et al. [3] demonstrated, in human studies, that maternal oxytocin release was inhibited by exogenous opioids in the first stage of labour. This effect could have been achieved by a direct action on oxytocin neurons in the hypothalamus and neurohypophysis, or indirectly via effects upon neural pathways that impinge upon oxytocin-secreting neurons [4, 5] .
The measurement of circulating endogenous opioid levels in humans may not reflect true interactions at the level of hypothalamus or the posterior pituitary. Thus the mechanisms may only be elucidated by studying the effects of the exogenous administration of opiates. We hypothesized that the blockade of spinal pain pathways with opiates could result in altered oxytocin secretion. The present study was conducted to explore further the inhibitory control of oxytocin secretion by opioids.
METHODS

Subjects
A total of 20 healthy women of 37 weeks ' gestation with a singleton pregnancy presenting for elective caesarean delivery were randomly allocated into two groups. Randomization was achieved using sealed brown envelopes that were shuffled and then subsequently labelled alphabetically (A-T) in sequence. After obtaining informed consent from the subject, each envelope was taken in sequence and the prescribed treatment was administered. The laboratory scientists who assayed the samples for oxytocin concentration were not aware of the particular treatment group. None of the subjects in either group had received any opioid or oxytocics for 12 h prior to the administration of spinal anaesthesia. The participating women gave written informed consent to take part, and the local research and ethics committee approved the study.
Sampling technique
In the operating room, the women took up a supine position, with a wedge under the right hip to provide left lateral tilt to prevent aorto-caval compression. Noninvasive blood pressure monitoring, ECG and pulse oximetry were instituted. Before obtaining the first study blood sample, an indwelling 16 G intravenous cannula was inserted under local anaesthetic in the left forearm to allow preloading of 500 ml of haemaccel (Hoechst UK Ltd, Hounslow, Middx., U.K.) ; no further fluids were infused until the last sample of blood was withdrawn. The vein was kept open using a slow infusion of lactated Ringer's solution, and blood pressure was maintained with intravenous ephedrine injected intermittently as necessary. A second 16 G intravenous cannula with a three-way stop valve was then sited under local anaesthesia in the right antecubital vein for sequential blood sampling. A total of ten samples of 4.5 ml of blood were withdrawn (one sample every 60 s) into pre-cooled disposable syringes before spinal intrathecal administration of the prescribed treatment. The blood samples were then transferred to previously prepared chilled and labelled tubes for centrifugation. The sampling site was flushed with 0.9 % saline and capped.
Immediately after completion of the first set of blood samples, the women were placed in the right lateral position, and the spinal anaesthetic was administered according to the prescribed treatment. Group I (n l 10) received 3 ml of hyperbaric bupivacaine 0.5 % (15 mg ; Astra Pharmaceuticals, Kings Langley, Herts. U.K.) plus fentanyl (25 µg ; Janssen-Cilag Ltd, High Wycombe, Bucks., U.K.). Group II (n l 10) received bupivacaine (15 mg) alone. The treatment was administered intrathecally. Acceptable levels of anaesthesia and analgesia were achieved, and none of the women required any additional analgesia during the procedure. Sensory levels were assessed by loss of sensation to pin prick (Neurotip ; Owen Mumford, Woodstock, Oxon., U.K.).
Once the sensory anaesthetic level reached T6 (thoracic) dermatome (within 10 min after intrathecal injection), the first 3 ml of blood was aspirated and discarded from the saline-flushed sampling site. A further ten samples (post-treatment) of 4.5 ml of blood were withdrawn (one every 60 s), and treated as described above. No oxytocin was administered for clinical purposes until the last sample had been withdrawn. The interval between the intrathecal injection of the treatment drug and the beginning of the second set of blood samples was similar in both groups, i.e. 10 min.
Each blood sample was dispensed immediately after collection into a separate chilled glass tube containing 0.05 mol\l EDTA and phenanthrolene solution [100 µl of a 2.5 % (w\v) solution] to inhibit oxytocinase activity. Samples were centrifuged within 10 min of sampling in a pre-cooled centrifuge (4 mC) at 4500 rev.\min for 10 min. The supernatant plasma (approx. 2 ml) was aspirated using disposable plastic pipettes to avoid sample contamination. The aspirated plasma was then flash-frozen in liquid nitrogen. The frozen samples were despatched in boxes containing solid CO # to the Babraham Institute (Cambridge, U.K.) for oxytocin extraction and subsequent assay. The laboratory scientists were not informed of the treatment given to a particular subject.
Assay of oxytocin
Oxytocin was extracted from plasma within 10 days, and in most cases within 2 days, using C
")
Plus Sep Pak Cartridges (Waters Chromatography, Milford, MA, U.S.A.). The extraction process and RIA were as described by Thornton et al. [6] , using an antiserum described previously [7] . The limit of detection of the assay was 2.91 pmol\l, and the inter-assay and intra-assay coefficients of variation were 10.62 % and 4.08 % respectively.
Statistical analysis
The average values before treatment for each subject, and the average values after treatment for each subject, were used. Logarithms of the means were used for analysis to reduce skewness. Data were analysed using a one-tailed Student's t-test ; a P value of 0.05 was considered significant.
RESULTS
Using one-sample t-statistics, there was no evidence from the data for a general difference in mean levels of oxytocin between the period before treatment (T l 1.35, P l 0.19) and the period after treatment (T l 1.12, P l 0.28). This was true whether comparisons were made within the two groups or in the combined group of 20 subjects. When Spinal fentanyl effect on oxytocin secretion No specific trend of a rise or fall in oxytocin levels was found in either group. Group I, bupivacaine plus fentanyl ; Group II, bupivacaine only.
sample values at any specific sampling time were examined, there was no evidence for any general difference between the two treatment groups (T l 0.13, P l 0.89). The subjects in the two groups were comparable with regard to mean age, height, weight and gestation period. There were no significant differences between the two groups in height of block, time to achieve T6 block, blood pressure or the mean ephedrine requirement (Table  1) . When compared within individual subjects in both groups, plasma oxytocin concentrations showed no significant change following either treatment (Table 2 ). In addition, the mean oxytocin levels in individual subjects in the pre-and post-treatment phases showed no clear tendency to rise or fall in either group (Figure 1 ).
DISCUSSION
The mechanisms involved in the control of oxytocin secretion may be relevant in attempts to understand the mechanisms of the onset and progress of labour. Oxytocin is synthesized in the cell bodies of the magnocellular neurons of the supraoptic and paraventricular nuclei, and transported down the axons of these neurons to their endings in the posterior lobe of the pituitary gland. The supraoptic and paraventricular nuclei contain high densities of receptors for µ and κ opioids, which potently inhibit the electrical activity of oxytocin-secreting neurons whether given centrally or systemically [8] . An involvement of oxytocin has been proposed in sexual behaviour [9] , maternal behaviour [10] , ovarian function [11] , milk ejection [12] and the progression of parturition [13] .
The ascending control of oxytocin secretion by endogenous opioids has been discussed previously by Leng et al. [14] , who suggested that neurons of the nucleus tractus solitarius (80 % noradrenergic) project directly to the oxytocin neurons of the supraoptic nuclei and relay afferent stimuli arising from the birth canal during parturition. These noradrenergic neurons can be activated by the systemic administration of cholecystokinin, resulting in increased secretory activity of oxytocinsecreting neurons. Morphine potently inhibits oxytocin release during parturition and following cholecystokinin administration [15] .
The role of oxytocin in normal parturition is unclear. Oxytocin receptor concentrations do not generally increase in uterine tissues until progesterone concentrations in the blood have declined. In humans, oxytocin receptor concentrations in the uterus are higher in women at term in labour than in term women not in labour [16] , enabling smaller amounts of oxytocin in the bloodstream to produce uterotonic effects. Oxytocin secretion does not rise until just before the expulsion phase of parturition (e.g. in the rat [17] , the pig [18] and the rabbit [19] ), at which time secretion becomes highly pulsatile [20, 21] .
The administration of oxytocin before labour can accelerate or delay parturition, depending on species, dose and method of administration [22, 23] . In clinical settings, oxytocin is used to induce labour in pregnant women at term. In human labour the main stimulus to hypothalamic oxytocin secretion has been reported to be ascending nervous signals from the excited or stretched tissues of the uterus, cervix and vagina [24] . Strong induction of neural activity (as measured by c-fos activation) has been recorded in brain stem nuclei as a result of parturition [25] . However, the pathway by which such signals might reach the brain may not be exclusively via the spinal cord, since pelvic neurectomy fails to prevent oxytocin secretion in the parturient rat [17] , and Fuchs and Dawood [19] reported elevated oxytocin secretion in parturient rabbits in which the spinal cord had been transected at T5. It may be that ascending autonomic pathways are involved. In addition, Gilbert et al. [20] reported that only a small proportion of oxytocin release at birth could be directly temporally related to vagino-cervical distension.
There are several possible reasons why lumbar intrathecal fentanyl had no effect on oxytocin secretion in the present study. In summary, we failed to identify any interaction between a spinal anaesthetic with and without fentanyl on oxytocin secretion in pregnant women who were not in labour at term.
